We undertake the prior authorization process, verifying benefits and liaising with your insurer for approvals, embracing you with clarity and removing financial uncertainties
This eliminates the bait-and-switch pricing that some platforms use, where the advertised price only applies to the lowest dose tier
Over 70% of patients report satisfaction with the final outcome
Instead, it should be interpreted with a qualified healthcare provider to support a more nuanced conversation: combining your genetic predispositions, hormonal biomarkers, and clinical history helps your provider personalize whether compounded GLP-1 treatment and dosing strategy align with your unique physiology
Plasma GDF-15 was performed as an in-house microtitre plate-based two-site electrochemiluminescence immunoassay using the MesoScale Discovery assay platform (MSD, Rockville, Maryland, USA)